Curis Stock (NASDAQ: CRIS) stock price, news, charts, stock research, profile.
Open | $10.950 |
Close | $10.870 |
Volume / Avg. | 23.493K / 34.081K |
Day Range | 10.410 - 10.950 |
52 Wk Range | 3.800 - 20.000 |
Market Cap | $64.069M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 0.93% |
Days to Cover | 1.4 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Curis (NASDAQ: CRIS) through any online brokerage.
Other companies in Curis’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Kezar Life Sciences (NASDAQ:KZR), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS) and Burning Rock Biotech (NASDAQ:BNR).
The latest price target for Curis (NASDAQ: CRIS) was reported by HC Wainwright & Co. on Friday, February 9, 2024. The analyst firm set a price target for 26.00 expecting CRIS to rise to within 12 months (a possible 139.19% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Curis (NASDAQ: CRIS) is $10.87 last updated Today at March 28, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Curis.
Curis’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Curis.
Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.